AI in Clinical Trials: Early Use Cases and Innovations, Upcoming Webinar Hosted by Xtalks
TORONTO, July 30, 2025 /PRNewswire/ -- In this free webinar, discover practical use cases of AI in clinical trials —...
Staff
Flow Sciences Announces New Office in North Carolina’s Research Triangle Park
LELAND, N.C., July 30, 2025 /PRNewswire/ -- Flow Sciences, a global leader in advanced containment solutions, today announced the opening...
Vanessa Colella Appointed as President and Chief Executive Officer of Blue Shield of California Sister Company, Stellarus
Colella takes the helm at the newly-formed healthcare technology company that aims to modernize health plans via its artificial intelligence-driven...
Cortechs.ai Announce Next-Gen NeuroQuant® Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation
SAN DIEGO, July 30, 2025 /PRNewswire/ -- Cortechs.ai, a pioneer in AI-powered medical imaging solutions, is pleased to announce the immediate...
Emerald Clinical Trials Confirms CEO Transition and Continuity Plan
SINGAPORE, July 30, 2025 /PRNewswire/ -- Emerald Clinical Trials, a leading global clinical research organization, today announced a leadership transition....
PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
NEW YORK, July 30, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating...
Trinity Capital Inc. Provides $20 Million in Growth Capital to b.well Connected Health
PHOENIX, July 30, 2025 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment...
Subtle Medical Among First to Achieve ISO/IEC 42001:2023 Certification for AI Management
The certification reinforces the company's leadership in AI safety, efficacy, and ethical governance. MENLO PARK, Calif., July 30, 2025 /PRNewswire/...
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
Funding will support commercialization in the USA and Europe as well as continued development of MAGENTIQ COLO's advanced AI capabilities....
Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
Test Finder interprets provider questions in context to deliver curated, clinically relevant results, going beyond traditional search Developed in collaboration...
Galaxy Therapeutics Opens New Manufacturing Facility to Support Global Commercialization
MILPITAS, Calif., July 30, 2025 /PRNewswire/ -- Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain...
Survey Finds Medtechs Lack Confidence in Regulatory Data Quality
Veeva MedTech report reveals opportunity to move beyond manual processes for speed and compliance PLEASANTON, Calif., July 30, 2025 /PRNewswire/...
InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins
YOKNEAM, Israel, July 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies,...
IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals
WESTBROOK, Maine, July 30, 2025 /PRNewswire/ -- IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today...
HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized...
Red Light Holland CEO Todd Shapiro Invited by Blockchain Futurist Conference for Fireside Chat and Panel Hosting
Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Life Backup Plan by Galacxia, Inc Announces $45K in Funding to Expand Its AI-Powered Health and Safety App
Aliso Viejo, CA, July 30, 2025 (GLOBE NEWSWIRE) -- Life Backup Plan by Galacxia, Inc, redefining how individuals and care...
Arbor Biotechnologies Announces First Patient Dosed at Mayo Clinic in the redePHine Phase 1/2 Study of ABO-101, an Investigational Gene Editing Treatment for Primary Hyperoxaluria Type 1
- ABO-101 was well tolerated with no serious adverse events or dose-limiting toxicities reported in the 28-days following dosing -...
Vivos Therapeutics Adds to Management Team to Support Expansion and Growth
Two Key Hires Add Significant Experience and Strengthen Vivos’ Ability to Scale Its Promising New Sleep Testing Center and Direct...
Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin
– New patent enhances market position in Europe HOUSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX)...